A year ago, Łukasz Bzdzion, CEO of Bioceltix, was second in the prestigious „Most Creative People in Business” ranking. Today, as the latest edition of the ranking is published, we get introduced to a new lineup of business leaders. We’re keeping our fingers crossed and hope you are too…and while you do that, why not read through this interview with our CEO.
Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets ...Article
Forbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the economy and probably all of us. In the coming weeks and months of 2021 it will be similar. The condition of start-ups is no exception here. it is easier and ...Article
According to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large group of companies is choosing NewConnect. As many as 63 companies declared their willingness to enter the alternative market, and several more in the ...Article
Gazeta Wrocławska wrote about us: “Bioceltix is working on innovative biological medicines used in the treatment of common autoimmune and inflammatory diseases in companion animals. The company from Wrocław has something to fight for. This is indicated by the numbers on the global drug ...Article
We create at Bioceltix veterinary biological medicines, and in 2020 we announced plans for a stock exchange debut and we obtained a permit from the Main Pharmaceutical Inspector to manufacture veterinary biological drugs. Despite the pandemic, we continue our projects without downtime. You can ...Article
Radio dla Ciebie: Yesterday (May 27) Łukasz Bzdzion from Bioceltix – the biotech startup that was recently recognized during European Startup Day ...Read full
Money: Scientists from Wroclaw are working on breakthrough drugs for dogs, horses and cats. They are being supported by experienced investors. ...Read full